BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 14724586)

  • 1. Effect of merlin phosphorylation on neurofibromatosis 2 (NF2) gene function.
    Surace EI; Haipek CA; Gutmann DH
    Oncogene; 2004 Jan; 23(2):580-7. PubMed ID: 14724586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serine 518 phosphorylation modulates merlin intramolecular association and binding to critical effectors important for NF2 growth suppression.
    Rong R; Surace EI; Haipek CA; Gutmann DH; Ye K
    Oncogene; 2004 Nov; 23(52):8447-54. PubMed ID: 15378014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neurofibromatosis type 2 (NF2)].
    Araki N; Takeshima H; Saya H
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurofibromatosis 2 tumor suppressor, the gene induced by valproic acid, mediates neurite outgrowth through interaction with paxillin.
    Yamauchi J; Miyamoto Y; Kusakawa S; Torii T; Mizutani R; Sanbe A; Nakajima H; Kiyokawa N; Tanoue A
    Exp Cell Res; 2008 Jul; 314(11-12):2279-88. PubMed ID: 18486129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NF2: the wizardry of merlin.
    Xiao GH; Chernoff J; Testa JR
    Genes Chromosomes Cancer; 2003 Dec; 38(4):389-99. PubMed ID: 14566860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Phosphorylation status of merlin is important for regulating the Ras-ERK pathway.
    Jung JR; Kim H; Jeun SS; Lee JY; Koh EJ; Ji C
    Mol Cells; 2005 Oct; 20(2):196-200. PubMed ID: 16267393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization and functional domains of the neurofibromatosis type II tumor suppressor, merlin.
    Shaw RJ; McClatchey AI; Jacks T
    Cell Growth Differ; 1998 Apr; 9(4):287-96. PubMed ID: 9563848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution and origin of merlin, the product of the Neurofibromatosis type 2 (NF2) tumor-suppressor gene.
    Golovnina K; Blinov A; Akhmametyeva EM; Omelyanchuk LV; Chang LS
    BMC Evol Biol; 2005 Dec; 5():69. PubMed ID: 16324214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of cellular proteins that interact with the NF2 tumor suppressor gene product.
    Takeshima H; Izawa I; Lee PS; Safdar N; Levin VA; Saya H
    Oncogene; 1994 Aug; 9(8):2135-44. PubMed ID: 8035998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of chicken Nf2/merlin indicates regulatory roles in cell proliferation and migration.
    Chen Y; Gutmann DH; Haipek CA; Martinsen BJ; Bronner-Fraser M; Krull CE
    Dev Dyn; 2004 Mar; 229(3):541-54. PubMed ID: 14991710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-suppression functions of merlin are independent of its role as an organizer of the actin cytoskeleton in Schwann cells.
    Lallemand D; Saint-Amaux AL; Giovannini M
    J Cell Sci; 2009 Nov; 122(Pt 22):4141-9. PubMed ID: 19910496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of cell adhesion by expression of the mutant neurofibromatosis type 2 (NF2) genes which lack exons in the ERM-homology domain.
    Koga H; Araki N; Takeshima H; Nishi T; Hirota T; Kimura Y; Nakao M; Saya H
    Oncogene; 1998 Aug; 17(7):801-10. PubMed ID: 9779996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magicin, a novel cytoskeletal protein associates with the NF2 tumor suppressor merlin and Grb2.
    Wiederhold T; Lee MF; James M; Neujahr R; Smith N; Murthy A; Hartwig J; Gusella JF; Ramesh V
    Oncogene; 2004 Nov; 23(54):8815-25. PubMed ID: 15467741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Akt phosphorylation regulates the tumour-suppressor merlin through ubiquitination and degradation.
    Tang X; Jang SW; Wang X; Liu Z; Bahr SM; Sun SY; Brat D; Gutmann DH; Ye K
    Nat Cell Biol; 2007 Oct; 9(10):1199-207. PubMed ID: 17891137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional analysis of the relationship between the neurofibromatosis 2 tumor suppressor and its binding partner, hepatocyte growth factor-regulated tyrosine kinase substrate.
    Sun CX; Haipek C; Scoles DR; Pulst SM; Giovannini M; Komada M; Gutmann DH
    Hum Mol Genet; 2002 Dec; 11(25):3167-78. PubMed ID: 12444101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional analysis of the neurofibromatosis type 2 protein by means of disease-causing point mutations.
    Stokowski RP; Cox DR
    Am J Hum Genet; 2000 Mar; 66(3):873-91. PubMed ID: 10712203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Merlin/neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac.
    Morrison H; Sperka T; Manent J; Giovannini M; Ponta H; Herrlich P
    Cancer Res; 2007 Jan; 67(2):520-7. PubMed ID: 17234759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of the NF2 tumor suppressor protein merlin in DU145 prostate cancer cells.
    Horiguchi A; Zheng R; Shen R; Nanus DM
    Prostate; 2008 Jun; 68(9):975-84. PubMed ID: 18361411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional analysis of neurofibromatosis 2 (NF2) missense mutations.
    Gutmann DH; Hirbe AC; Haipek CA
    Hum Mol Genet; 2001 Jul; 10(14):1519-29. PubMed ID: 11448944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interdomain binding mediates tumor growth suppression by the NF2 gene product.
    Sherman L; Xu HM; Geist RT; Saporito-Irwin S; Howells N; Ponta H; Herrlich P; Gutmann DH
    Oncogene; 1997 Nov; 15(20):2505-9. PubMed ID: 9395247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.